The hospital pharmacists’ role in treating patients with epilepsy starts with their place on the multidisciplinary team, which identifies appropriate drug selection in the hospital. It continues with counseling and therapy reconciliation to assure smooth transitions upon patient discharge to the community.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
The ease of administration with new agents for schizophrenia via an injection is advantageous because this patient population is commonly agitated and difficult to administer oral medications to.
Both ibrutinib (Imbruvica) and venetoclax (Venclexta) carry an approved indication for use in chronic lymphocytic leukemia but do not often lead to complete remission, and therapy routinely continues indefinitely or until disease progression.
The tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
Five tips to keep in mind before you begin your IPPEs.
After carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Cases discuss patients with medication allergies and drug interactions.
Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Examining the clinical applications, effectiveness, safety, and regulation of herbal supplements with a focus on the role of pharmacists.
There are a number of ways in which job design and working conditions can be improved in the community pharmacy setting, either on the store level or on an organization-wide basis.
These disorders can be fatal, making pharmacists’ role in detection crucial.
Tapping their specific skill sets and training can help serve patients more effectively, although challenges exist.
Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
As pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.
Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.
Panelists discuss how long-term safety monitoring for second-line primary biliary cholangitis (PBC) therapies requires systematic assessment of liver function, lipid profiles, and potential drug-specific adverse effects while emerging 5-year safety data for seladelpar continues to demonstrate a favorable risk profile compared with other treatment options.
Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.
On the heels of Women Pharmacist Day on October 12, we highlight 3 female pharmacists who have followed unique career paths that help to drive innovation and change in the industry, beyond the retail pharmacy setting.
Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.
Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.
Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
The adjuvant therapy has demonstrated varied efficacy for patients.
IMROZ study data show Isa-VRd may be a new standard of care.